Sponsor:
VM Oncology, LLC
Code:
NCT03556228
Conditions
Head and Neck Carcinoma
Adenoid Cystic Carcinoma
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
VMD-928 300 mg Tablet (ongoing); 100 mg Capsule (complete)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-17. This information was provided to ClinicalTrials.gov by VM Oncology, LLC on 2025-06-24.